Top View
- PSILOCIN PSILOCYBIN Latest Revision: June 27, 2005
- Legal Status of Psychedelic Drugs and Research Involving Possible Medical Uses
- 2019 National Survey on Drug Use and Health: Detailed
- The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations
- The Therapeutic Potential of Psilocybin
- Analysis of Psilocybin and Psilocin in Psilocybe ´ Subcubensis GUZMAN by Ion Mobility Spectrometry and Gas Chromatography–Mas
- Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances NEPTUNE
- Magic Mushrooms Is Reported
- Signaling Mechanism Responsible for 5-HT2A Receptor Tolerance to Psychedelic Induced Head-Twitch Behavior in Mice
- Psychedelic Support a Practical Guide to Establishing and Facilitating Care Services at Music Festivals and Other Events
- Overview of the Major Classes of New Psychoactive Substances
- Clinical Trials of Psilocybin and Ecstasy As Treatments for Depression And
- Psychedelics, Trauma & Addiction
- Psychedelics Revamped Effect on Mortality12
- Metabolism of Psilocybin and Psilocin: Clinical and Forensic Toxicological Relevance
- Psilocybin Mushrooms Are Found in Mexico, Central America, and the United States
- Alpha-Methyltryptamine (AMT)
- The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients
- The Pharmacology of D-Lysergic Acid Diethylamide (LSD)
- Altered States of Consciousness Drug‐Induced States David E
- Use of MDMA & Psilocybin in the Treatment of PTSD
- Effect of Lysergic Acid Diethylamide (LSD) on Reinforcement Learning in Humans
- Occurrence and Use of Hallucinogenic Mushrooms Containing Psilocybin Alkaloids
- The Potential Role of Serotonergic Hallucinogens in Depression Treatment
- Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: a Systematic Review
- Hallucinogens and Dissociative Drug Use and Addiction
- Hallucinogen Actions on Human Brain Revealed
- The Hallucinogenic Brain: Diagnosis and Treatment
- N,N-Dimethyltryptamine and Its Analogs
- Legalizing Marijuana, Psilocybin Mushrooms, and MDMA for Medical Use
- Magic Mushroom' Ingestion N
- Lysergic Acid Diethylamide (LSD) David E
- Global Drug Survey 2019 (Gds2019)
- New Psychoactive Substances in Poland: an Overview of Psychodysleptics (Lysergamides and Tryptamines)
- Characterization of the Discriminative Stimulus Effects of Nitrous Oxide
- The Hallucinogenic World of Tryptamines: an Updated Review
- Federal Register/Vol. 84, No. 142/Wednesday, July 24, 2019/Notices
- Chemistry and Structure–Activity Relationships of Psychedelics
- Bioactive Alkaloids of Hallucinogenic Mushrooms
- Psychedelics in the Treatment of Mood and Substance Use Disorders
- Toxicology and Analysis of Psychoactive Tryptamines
- The Relationship Between Psilocybin/Psilocin Plasma Levels and Receptor Occupancy: PET Imaging with 11C-Cimbi-36
- The Pharmacology of Lysergic Acid Diethylamide: a Review Torsten Passie1,Johnh.Halpern2,3, Dirk O
- BUFOTENINE Latest Revision: August 16, 2005
- Psilocybin Investigator's Brochure
- Lysergic Acid Diethylamide (LSD) and Psilocybin for the Manage- Ment of Patients with Persistent Pain: a Potential Role? Pain Management, 8 (3)
- Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task
- Determination of Psilocin and Psilocybin in Magic Mushrooms
- Quantitation of Psilocybin and Psilocybin in Mushroom by LC-MS
- Pharmacological Characterization of the LSD Analog N-Ethyl-N-Cyclopropyl Lysergamide (ECPLA)
- AMT Fast Facts
- ALPHA-METHYLTRYPTAMINE (Street Name: Spirals) February 2020
- 5-Meo-AMT? What Does 5-Meo-AMT Look Like? Who Abuses 5-Meo-AMT?
- Oregon Psilocybin Advisory Board Rapid Evidence Review and Recommendations
- For Peer Review Journal: Drug Testing and Analysis